Immunoglobulin fragments
Showing 1 - 25 of 1,113
COVID-19 Trial in Monterrey (Placebo, Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS))
Recruiting
- COVID-19
- Placebo
- Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS)
-
Monterrey, Nuevo Leon, MexicoHospital San José
Oct 20, 2021
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
Diarrhea-Associated Hemolytic Uremic Syndrome, Pediatric Kidney Disease, Hemolytic-Uremic Syndrome Trial in Argentina (INM004,
Recruiting
- Diarrhea-Associated Hemolytic Uremic Syndrome
- +2 more
- INM004
- SoC
-
Bahía Blanca, Buenos Aires, Argentina
- +15 more
Jan 6, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- +4 more
-
Tempe, ArizonaCelerion
Aug 15, 2023
Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)
Not yet recruiting
- Metabolic-associated Fatty Liver Disease
- Type 2 Diabetes
- Empagliflozin
- +2 more
- (no location specified)
Oct 1, 2022
Circulating Tumor DNA to Monitor Efficacy of Total Neoadjuvant
Not yet recruiting
- Colorectal Cancer
- Rectal Cancer
- SignateraTM assay
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 5, 2023
Acute Kidney Injury Trial in Baltimore (Digoxin Antibodies Fab Fragments, Placebo)
Recruiting
- Acute Kidney Injury
- Digoxin Antibodies Fab Fragments
- Placebo
-
Baltimore, Maryland
- +1 more
Dec 15, 2021
Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,
Recruiting
- Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- Hydroxyurea
- Luspatercept
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Thalassemia Major, Transfusion-dependent Anemia Trial in Guangzhou (Luspatercept Injectable Product)
Recruiting
- Thalassemia Major
- Transfusion-dependent Anemia
- Luspatercept Injectable Product
-
Guangzhou, Guangdong, ChinaThe second affiliated hospital of Sun Yat-sen University
Jul 15, 2022
Fecal Incontinence Trial in Winston-Salem (Muscle Fiber Fragment (MFF) Injections)
Recruiting
- Fecal Incontinence
- Muscle Fiber Fragment (MFF) Injections
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jan 26, 2023
MRD Detection by NGS in Pediatric B-ALL
Completed
- Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
- MRD
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023
Human Microecology Assisted Diagnosis of Colorectal Cancer
Recruiting
- Human Microecology;Colorectal Disease;Auxiliary Diagnosis
- observe only
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Aug 17, 2023
Specific Hyperimmune Equine Serum for Treatment of Severe
Completed
- Covid19
-
Corrientes, ArgentinaHospital de Campaña "Escuela Hogar"
Mar 28, 2022
Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)
Not yet recruiting
- Epithelial Ovarian Cancer
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 4, 2022
Kidney Stone, Ureteral Stone Trial in Chicago (Dusting, Basket extraction)
Recruiting
- Kidney Stone
- Ureteral Stone
- Dusting
- Basket extraction
-
Chicago, IllinoisNorthwestern Memorial Hospital
Jan 30, 2023
Distal Radius Fracture Trial (Minimal invasive surgical fixation of distal radius Fractures)
Not yet recruiting
- Distal Radius Fracture
- Minimal invasive surgical fixation of distal radius Fractures
- (no location specified)
Jul 18, 2022
Immunoglobulin E-Mediated Food Allergy, Immunoglobulin G4-Related Disease, Symptoms and Signs Trial in Madrid (Food-specific
Recruiting
- Immunoglobulin E-Mediated Food Allergy
- +3 more
- Food-specific Immunoglobulin G4 and/or Immunoglobulin E antibody reactions
-
Madrid, SpainUniversidad Politécnica de Madrid
Jan 3, 2023
Lymphoma Trial in Seattle (biological, other, procedure)
Not yet recruiting
- Lymphoma
- Immune Globulin Infusion (Human), 10% Solution
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2023
Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)
Completed
- Covid-19 Patients
- Cupping therapy with convential medical treatment
- Convential medical treatment
-
Giza, EgyptFaculty of physical therapy
Jun 11, 2023
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune
Recruiting
- CIDP
- +2 more
- Intravenous immune globulin G
- Subcutaneous immune globulin G
-
New Brunswick, New JerseyRutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022
Nephrolithiasis Trial in Montréal (Massage Percussion Therapy device)
Not yet recruiting
- Nephrolithiasis
- Massage Percussion Therapy device
-
Montréal, CanadaUniversity of Montreal
May 12, 2023
Retained Drug Needle Fragments in People Who Use Intravenous
Not yet recruiting
- Drug Abuse, Intravenous
- +4 more
- Low-dose X-ray of subcutaneous tissues
- (no location specified)
Jan 9, 2023
Pre-analytical Factors Affecting ctDNA Analysis in Early and
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +4 more
- Biospecimen Collection
- Electronic Health Record Review
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jul 6, 2023
Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)
Recruiting
- Kidney Transplantation in Highly Sensitized Patients
- Imlifidase
- +5 more
-
Birmingham, Alabama
- +12 more
Jan 12, 2023
At-Home Subcutaneous Immunoglobulin Replacement Therapy Using
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- No Intervention
- (no location specified)
Nov 21, 2023